Literature DB >> 29445535

Clinical update on central hypersomnias.

Laura Pérez-Carbonell1, Guy Leschziner1,2.   

Abstract

The central hypersomnias encompass a range of conditions causing persisting or intermittent excessive daytime sleepiness (EDS). These conditions therefore present not infrequently in general clinical sleep practice, and remain in the differential for patients presenting with sleepiness. Our understanding of the pathophysiology, diagnosis and management of these conditions has progressed significantly over recent years, and in this article we review this group of disorders, focussing in particular on recent changes in classification and diagnosis, pathophysiological advances, and novel treatment options.

Entities:  

Keywords:  Kleine-Levin; Narcolepsy; hypersomnia; sleep disorders

Year:  2018        PMID: 29445535      PMCID: PMC5803059          DOI: 10.21037/jtd.2017.10.161

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  96 in total

1.  Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.

Authors:  Smaranda Leu-Semenescu; Nandy Nittur; Jean-Louis Golmard; Isabelle Arnulf
Journal:  Sleep Med       Date:  2014-03-18       Impact factor: 3.492

2.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

3.  Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Christelle Monaca Charley; Patricia Franco; Xavier Drouot; Marie-Pia d'Ortho; Sandrine Launois; Séverine Lignot; Patrice Bourgin; Béatrice Nogues; Marc Rey; Sophie Bayard; Sabine Scholz; Sophie Lavault; Pascale Tubert-Bitter; Cristel Saussier; Antoine Pariente
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

4.  Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Authors:  Syed Sohail Ahmed; Wayne Volkmuth; José Duca; Lorenzo Corti; Michele Pallaoro; Alfredo Pezzicoli; Anette Karle; Fabio Rigat; Rino Rappuoli; Vas Narasimhan; Ilkka Julkunen; Arja Vuorela; Outi Vaarala; Hanna Nohynek; Franco Laghi Pasini; Emanuele Montomoli; Claudia Trombetta; Christopher M Adams; Jonathan Rothbard; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

5.  Serum cytokine levels in Kleine-Levin syndrome.

Authors:  Birgitte Rahbek Kornum; Thomas Rico; Ling Lin; Yu-Shu Huang; Isabelle Arnulf; Poul Jennum; Emmanuel Mignot
Journal:  Sleep Med       Date:  2015-05-15       Impact factor: 3.492

6.  The association between narcolepsy and REM behavior disorder (RBD).

Authors:  S Nightingale; J C Orgill; I O Ebrahim; S F de Lacy; S Agrawal; A J Williams
Journal:  Sleep Med       Date:  2005-05       Impact factor: 3.492

7.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Authors:  Yves Dauvilliers; Claudio Bassetti; Gert Jan Lammers; Isabelle Arnulf; Geert Mayer; Andrea Rodenbeck; Philippe Lehert; Claire-Li Ding; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

8.  Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome.

Authors:  Jing Yu Wang; Fang Han; Song X Dong; Jing Li; Pei An; Xiao Zhe Zhang; Yuan Chang; Long Zhao; Xue Li Zhang; Ya Nan Liu; Han Yan; Qing Hua Li; Yan Hu; Chang Jun Lv; Zhan Cheng Gao; Kingman P Strohl
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

9.  Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.

Authors:  Olivier Andlauer; Hyatt Moore; Seung-Chul Hong; Yves Dauvilliers; Takashi Kanbayashi; Seiji Nishino; Fang Han; Michael H Silber; Tom Rico; Mali Einen; Birgitte R Kornum; Poul Jennum; Stine Knudsen; Sona Nevsimalova; Francesca Poli; Giuseppe Plazzi; Emmanuel Mignot
Journal:  Sleep       Date:  2012-09-01       Impact factor: 5.849

10.  ImmunoChip study implicates antigen presentation to T cells in narcolepsy.

Authors:  Juliette Faraco; Ling Lin; Birgitte Rahbek Kornum; Eimear E Kenny; Gosia Trynka; Mali Einen; Tom J Rico; Peter Lichtner; Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Sirous Javidi; Peter Geisler; Geert Mayer; Fabio Pizza; Francesca Poli; Giuseppe Plazzi; Sebastiaan Overeem; Gert Jan Lammers; David Kemlink; Karel Sonka; Sona Nevsimalova; Guy Rouleau; Alex Desautels; Jacques Montplaisir; Birgit Frauscher; Laura Ehrmann; Birgit Högl; Poul Jennum; Patrice Bourgin; Rosa Peraita-Adrados; Alex Iranzo; Claudio Bassetti; Wei-Min Chen; Patrick Concannon; Susan D Thompson; Vincent Damotte; Bertrand Fontaine; Maxime Breban; Christian Gieger; Norman Klopp; Panos Deloukas; Cisca Wijmenga; Joachim Hallmayer; Suna Onengut-Gumuscu; Stephen S Rich; Juliane Winkelmann; Emmanuel Mignot
Journal:  PLoS Genet       Date:  2013-02-14       Impact factor: 5.917

View more
  3 in total

Review 1.  pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

Authors:  Noeen Sarfraz; David Okuampa; Hannah Hansen; Mark Alvarez; Elyse M Cornett; Juyeon Kakazu; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-05-30

2.  Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.

Authors:  Adrienne Elisabeth van der Hoeven; Rolf Fronczek; Mink Sebastian Schinkelshoek; Frederik Willem Cornelis Roelandse; Jaap Adriaan Bakker; Sebastiaan Overeem; Denise Bijlenga; Gert Jan Lammers
Journal:  Sleep       Date:  2022-03-07       Impact factor: 6.313

3.  Sleep disturbance mediates the link between childhood trauma and clinical outcome in severe mental disorders.

Authors:  Jannicke Fjæra Laskemoen; Monica Aas; Anja Vaskinn; Akiah Ottesen Berg; Synve Hoffart Lunding; Elizabeth Ann Barrett; Ingrid Melle; Carmen Simonsen
Journal:  Psychol Med       Date:  2020-04-23       Impact factor: 7.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.